Cell line · CVCL_C1ND
KATO III Ola-R
Cancer cell line, Homo sapiens. Down syndrome. 1 paper.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. KATO III Ola-R. Cell lines, record CVCL_C1ND. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_C1ND
On this page
Cell line
As Cellosaurus gives it.
- Name
- KATO III Ola-R
- Accession
- CVCL_C1ND
- RRID
- RRID:CVCL_C1ND
- Synonyms
- KATO-III/olaparib-resistant, Olaparib-resistant KATO-III
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 57Y
- Category
- Cancer cell line
- Diseases
- Down syndrome (NCIt C2993); Gastric signet ring cell adenocarcinoma (NCIt C5250); Down syndrome (ORDO Orphanet_870)
- Derived from
- Pleural effusion (metastatic)
- Parent
- KATO III (CVCL_0371)
- Entry created
- 2022-09-22
- Entry updated
- 2024-12-19
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers1
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted |
|---|---|---|---|---|
| TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy. | Cancers (Basel) | 2020 | Cellosaurus cites it |
Source PubMed
Relatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Parent | KATO III | CVCL_0371 |
Source Cell lines
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_C1ND
GET https://conductscience.org/api/cell-lines/v1/CVCL_C1ND/problems